Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.079 519 179 381 %Companies according to biotechnology used: Genetic code 35 46 29 23 %Companies according to biotechnology used: Functional units 44 55 40 32 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 26 34 24 17 %Companies according to biotechnology used: Bioprocesses 49 42 46 61 %Companies according to biotechnology used: Sub-cellular organisms 8 12 6 5 %Companies according to biotechnology used: Bio-computing 23 35 15 10 %Companies according to biotechnology used: Nanobiotechnology 15 23 13 4 %Companies according to biotechnology used: Other 12 12 18 10 %Company by field(s) of ultimate application of biotechnology use: Human Health 48 68 43 22 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 21 25 15 17 %Company by field(s) of ultimate application of biotechnology use: Food products 33 25 30 46 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 22 21 22 %Company by field(s) of ultimate application of biotechnology use: Environment 17 15 25 17 %Company by field(s) of ultimate application of biotechnology use: Industry 15 16 20 10 Personnel in R&D in biotechnology (no. of persons) 9.795 5.614 1.560 2.621 Personnel in R&D in biotechnology (no. of persons): Researchers 5.573 3.578 874 1.122 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.222 2.036 686 1.500 Personnel in R&D in biotechnology (no. of persons): women 5.298 3.242 813 1.243 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.925 1.944 462 520 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.373 1.298 352 724 Personnel in R&D in biotechnology (FTE) 6.828,6 4.507,9 873,3 1.447,5 Personnel in R&D in biotechnology (FTE): Researchers 4.106,5 2.926,2 542,5 637,8 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.722,1 1.581,7 330,8 809,6 Personnel in R&D in biotechnology (FTE): women 3.811,7 2.613,9 467,5 730,3 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.190,7 1.587,2 290,9 312,7 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.621 1.026,8 176,7 417,6 Internal expenditure on R&D (thousands of euros) 533.826 364.396 71.517 97.913 1) By nature of the expense: Current expenses 492.955 336.315 63.751 92.889 1.1) Remuneration to researchers 203.439 146.489 27.774 29.176 1.2) Remuneration to technicians and assistants 96.850 59.163 11.408 26.279 1.3) Other current expenses 192.666 130.663 24.568 37.434 2) By nature of the expense: Capital expenses 40.870 28.081 7.766 5.024 2.1) Land and buildings 7.521 3.628 3.306 587 2.2) Equipment and instruments 32.078 23.504 4.431 4.144 2.3) Acquisition of specific R+D software 1.270 949 28 293 1) By origin of the funds: National funds 432.869 285.656 66.748 80.466 1.1) Own funds 319.046 209.128 49.733 60.186 1.2) From companies 39.253 26.512 5.269 7.473 1.3) Public Administration funds 70.063 47.559 11.542 10.962 1.4) From Universities 156 131 10 14 1.5) From non profit private institutions 4.351 2.326 194 1.831 1) By origin of the funds: Foreign funds 100.956 78.740 4.769 17.447 2.1) From EU programmes 20.070 15.152 3.718 1.200 2.2) Other foreign funds 80.886 63.588 1.051 16.247 Purchase of R&D services in biotechnology (thousands of euros) 138.625 109.756 20.480 8.390 Purchase of R&D services in biotechnology (thousands of euros): In Spain 101.114 75.199 17.964 7.950 Purchase of R&D services in biotechnology (thousands of euros): Abroad 37.512 34.557 2.515 440 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 46 57 43 33 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 12 15 14 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12 14 15 8 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 14 19 12 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 19 21 23 14 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 19 23 22 13 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 18 19 16 16 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 41 42 30 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 49 53 57 41 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 21 20 16 % Companies that have requested biotechnology patents 15 23 13 6 Number of patents requested 466 349 74 42 % Companies with income of an international origin related to biotechnological activities 24,9 33 14,5 18,8 % Turnover representing income of an international origin related to biotechnological activities 0,9 11,2 0 0,3 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 71,3 76,7 54,2 32 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 28,7 23,3 45,8 68 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 92,2 92,9 56,5 92,4 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 2,4 2,2 23,8 0,6 % Income of an international origin related with activities according to the classification: Operating source abroad 1,3 0,9 19,7 0,7 % Income of an international origin related with activities according to the classification: Other 4,2 4 . 6,3 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute